Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

FORMOTEROL FUMARATE DIHYDRATE

All products: Limited Use (codes 132)

Other products in the same Health Canada class (R03A, R03AC) — coverage varies; not interchangeable

  • Salbutamol (Teva-Salbutamol Sterinebs P.F.): general benefit, Limited Use 256, 257, 258, 259, Limited Use 265, 266, 267, 268, Not a benefit
  • Terbutaline (Bricanyl Turbuhaler): general benefit
  • Formoterol (Foradil): limited Use 132
  • Indacaterol (Onbrez Breezhaler): limited Use 443
  • Salmeterol (SereVent Diskus): limited Use 132, 391
  • Aclidinium + formoterol (Duaklir Genuair): limited Use 459

8 more in the class list below

Oxeze Turbuhaler · DIN 02237225 · 6mcg/Metered Dose · dry-powder inhaler, 60 doses

Limited Use — Reason for Use code 132 requiredMarketed · checked 2026-09-19
StatusLimited Use — Reason for Use code 132 required
Write on scriptLU code 132 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 132
Reason for Use code 132 For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms. Coverage limit: This drug is not for relief of acute symptoms. Coverage limit: LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Oxeze Turbuhaler · DIN 02237225 Manufacturer: AstraZeneca; listing date 2001-03-07 Health Canada: Marketed since 2016-06-01 · brand OXEZE TURBUHALER · ATC R03AC13 FORMOTEROL · form Powder · route Inhalation · ingredients FORMOTEROL FUMARATE DIHYDRATE 6 MCG/ACT · company Astrazeneca canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Oxeze Turbuhaler: Formulary list price $39.0700/unit (unit not stated in source; not the patient's cost)

Ministry pays: $39.0700 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60543 · Verify on the e-Formulary ↗ (DIN 02237225)

Source record
DIN 02237225: Oxeze Turbuhaler Raw flags: sec12=Y, sec3=Y Item: 121200082; group id 227; item number 0405; lccId 00037; manufacturer id AZC Source form: Pd Inh-60 Dose Pk; strength: 6mcg/Metered Dose Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $39.0700; ministry $39.0700 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02237225 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=60543
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (12:12 Sympathomimetic (Adrenergic) Agents) and how they are covered

Matched class: 12:12 Sympathomimetic (Adrenergic) Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: EPINEPHRINE HCL, TERBUTALINE SULFATE Some products covered without a code (check the product listing): ORCIPRENALINE SULFATE, SALBUTAMOL 12:12 Sympathomimetic (Adrenergic) Agents

SALBUTAMOL

· 20 products · Limited Use, codes 265, 266, 267, 268 (4), Listed, not a benefit (8), Limited Use, codes 256, 257, 258, 259 (1), General benefit (7) · strengths: 1mg/mL, 2mg/mL, 5mg/mL, 100mcg/Metered Dose, 2mg, 4mg · Inh Sol- 2.5mL Pk, Inh Sol-10mL Pk, Inh-200 dose Pk, Tab

TERBUTALINE SULFATE

· 2 products · General benefit · strengths: 0.5mg/Dose · Inh-100 Dose Pk, Inh-120 Dose Pk

FORMOTEROL FUMARATE

· 1 products · Limited Use, codes 132 · strengths: 12mcg/Cap · Inh Pd-Device Pk

INDACATEROL

· 1 products · Limited Use, codes 443 · strengths: 75mcg · Inh Pd-Cap

SALMETEROL XINAFOATE

· 1 products · Limited Use, codes 132, 391 · strengths: 50mcg · Pd Inh-60 Dose Pk

ACLIDINIUM BROMIDE & FORMOTEROL FUMARATE DIHYDRATE

· 1 products · Limited Use, codes 459 · strengths: 400mcg & 12mcg · Metered Dose Pd Inh-60 Dose Pk

BUDESONIDE & FORMOTEROL FUMARATE DIHYDRATE

· 2 products · Limited Use, codes 330 · strengths: 100mcg/6mcg, 200mcg/6mcg · Pd Inh-120 Dose Pk

BUDESONIDE&GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE)&FORMOTEROL FUMARATE DIHYDRATE

· 1 products · Limited Use, codes 638 · strengths: 160mcg & 7.2mcg & 5mcg/Act · Metered Dose Inh-120 Dose Pk

FLUTICASONE FUROATE & UMECLIDINIUM BROMIDE & VILANTEROL TRIFENATATE

· 1 products · Limited Use, codes 567 · strengths: 100mcg & 62.5mcg & 25mcg · Pd Inh-30 Dose Pk

FLUTICASONE FUROATE & VILANTEROL

· 2 products · Limited Use, codes 330, 456 (1), Limited Use, codes 330 (1) · strengths: 100mcg & 25mcg, 200mcg & 25mcg · Blister Pd Inh-30 Dose Pk

INDACATEROL & GLYCOPYRRONIUM

· 1 products · Limited Use, codes 459 · strengths: 110mcg & 50mcg · Inh Pd-Cap

MOMETASONE FUROATE & FORMOTEROL FUMARATE DIHYDRATE

· 2 products · Limited Use, codes 330 · strengths: 100mcg & 5mcg, 200mcg & 5mcg · Metered Dose Inh-120 Dose Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 12:12 and 4 more
Full class listing Related classes: 12:04 Parasympathomimetic (Cholinergic) Agents, 12:08 Parasympatholytic (Cholinergic Blocking) Agents, 12:20 Skeletal Muscle Relaxants Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE Asthma: OXEZE TURBUHALER (formoterol fumarate dihydrate) is indicated for the treatment of asthma only as add-on therapy to an inhaled corticosteroid, a long-term asthma control medication, in patients 6 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma. Corticosteroids should not be stopped because formoterol is prescribed. Formoterol is a long-acting beta2 agonist (LABA) and should not be used as a rescue medication. To relieve acute asthmatic symptoms a short-action inhaled bronchodilator should be used. LABA, such as formoterol, the active ingredient in OXEZE, may increase the risk of asthma- related death (see WARNINGS AND PRECAUTIONS). Use of OXEZE for the treatment of asthma without concomitant use of an inhaled corticosteroid, a long-term asthma control medication, is contraindicated (see CONTRAINDICATIONS). Use OXEZE only as add-on therapy for patients with asthma who are currently taking but are inadequately controlled on an inhaled corticosteroid. COPYRIGHT 2000-2018 ASTRAZENECA CANADA INC. Page 3 of 33 Once asthma control i… https://pdf.hres.ca/dpd_pm/00044980.PDF PM date: April 23, 2018 Source product: OXEZE TURBUHALER; DIN 02237224; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.